摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-chloro-6-(4-methoxyphenoxy)nicotinate

中文名称
——
中文别名
——
英文名称
methyl 2-chloro-6-(4-methoxyphenoxy)nicotinate
英文别名
Methyl 2-chloro-6-(4-methoxyphenoxy)pyridine-3-carboxylate;methyl 2-chloro-6-(4-methoxyphenoxy)pyridine-3-carboxylate
methyl 2-chloro-6-(4-methoxyphenoxy)nicotinate化学式
CAS
——
化学式
C14H12ClNO4
mdl
——
分子量
293.707
InChiKey
GBEYIHPZCHTWMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    57.6
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof
    申请人:SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD.
    公开号:US10100051B2
    公开(公告)日:2018-10-16
    A compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, a preparation method thereof and a pharmaceutical use thereof are provided. In particular, the compound has the following Formula (I), wherein R2 and R3 are each independently H; R1 is H or C1-C3 alkyl; Ar is an aromatic ring or a heteroaromatic ring selected from a naphthalene ring, a pyridine ring, a thiophene ring, a furan ring and a substituted benzene ring. Pharmaceutically acceptable salts of the present compound, are provided, as well as uses of the compound or pharmaceutically acceptable salts thereof in the preparation of a medicine for inhibiting HIF prolyl hydroxylase or a medicine for promoting the generation of endogenous EPO.
    本发明提供了一种被芳基氧基或杂芳基氧基取代的 5-羟基-1,7-萘啶的化合物、其制备方法及其药物用途。特别是,该化合物具有下式(I),其中 R2 和 R3 各自独立地为 H;R1 为 H 或 C1-C3 烷基;Ar 为选自萘环、吡啶环、噻吩环、呋喃环和取代苯环的芳环或杂芳环。提供了本化合物的药学上可接受的盐,以及本化合物或其药学上可接受的盐在制备抑制 HIF 脯氨酰羟化酶的药物或促进内源性 EPO 生成的药物中的用途。
  • COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYLOXY OR HETEROARYLOXY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF
    申请人:SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD.
    公开号:US20180118739A1
    公开(公告)日:2018-05-03
    A compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, a preparation method thereof and a pharmaceutical use thereof are provided. In particular, the compound has the following Formula (I), wherein R 2 and R 3 are each independently H; R 1 is H or C 1 -C 3 alkyl; Ar is an aromatic ring or a heteroaromatic ring selected from a naphthalene ring, a pyridine ring, a thiophene ring, a furan ring and a substituted benzene ring. Pharmaceutically acceptable salts of the present compound, are provided, as well as uses of the compound or pharmaceutically acceptable salts thereof in the preparation of a medicine for inhibiting HIF prolyl hydroxylase or a medicine for promoting the generation of endogenous EPO.
  • COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYLOXY OR HETEROOXY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF
    申请人:Shenyang Sunshine Pharmaceutical Co., Ltd.
    公开号:EP3275881B1
    公开(公告)日:2021-08-04
  • Highly Regioselective DABCO-Catalyzed Nucleophilic Aromatic Substitution (SNAr) Reaction of Methyl 2,6-Dichloronicotinate with Phenols
    作者:Yao-Jun Shi、Guy Humphrey、Peter E. Maligres、Robert A. Reamer、J. Michael Williams
    DOI:10.1002/adsc.200505431
    日期:2006.2
    Exclusive formation of 6-aryloxy ethers 9 from an SNAr reaction of methyl 2,6-dichloronicotinate (2) with phenols 7 catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO) in the presence of stoichiometric triethylamine is described. The reaction proceeds via the regioselective formation of an unprecedented DABCO-pyridine adduct 10a.
    在化学计量三乙胺的存在下,由1,4-二氮杂双环[2.2.2]辛烷(DABCO)催化的2,6-二氯烟酸甲酯(2)与酚7的S N Ar反应形成的6-芳氧基醚9是描述。该反应通过空前的DABCO-吡啶加合物10a的区域选择性形成而进行。
查看更多